|
6 Jul 2026
|
Others
|
Experimental Drug Development Centre
|
ScrambleBench: a workflow for comparative assessment of structure-based de novo generative models (Pending publish)
|
Veincent Yap,
Pan Xu,
Frankie S. Mak,
Klement Foo,
CongBao Kang,
Padmanabhan Anbazhagan,
Weijun Xu
|
Journal of Cheminformatics
|
|
24 Jun 2026
|
Others
|
Experimental Drug Development Centre
|
Protein dynamic simulations: From early inception to clinical translation over half a century (Pending publish)
|
Leyun Wu,
Pan Xu,
Bin Yu,
Weijun Xu,
Jinan Wang
|
Computational Biology and Chemistry
|
|
14 May 2026
|
Others
|
Experimental Drug Development Centre
|
From Serendipity to Rationality: Expanding Druggability by Molecular Glue Discovery (Pending publish)
|
David E. Heppner,
CongBao Kang,
Weijun Xu
|
Journal of Medicinal Chemistry
|
|
23 Apr 2026
|
Others
|
Experimental Drug Development Centre
|
Illuminating Clinical TEAD Inhibitors Through Structural Biology (Pending publish)
|
CongBao Kang,
Weijun Xu,
Haiwei Song,
Wanjin Hong
|
Journal of Medicinal Chemistry
|
|
26 Mar 2026
|
Others
|
Experimental Drug Development Centre
|
In Silico‐Enabled Discovery and Development of Potent and Selective CDK11 Inhibitors (Pending publish)
|
Frankie S. Mak,
Fui Mee Ng,
Padmanabhan Anbazhagan,
Vikas Madan,
Qian Wen Tan,
Yiyang See,
Diane Lim,
Frances Karla Kusuma,
Hannah Toh,
Juliana Mohammad,
Haiyan Yang,
Sandra Sim,
Li Hong Tan,
Eileen Tay,
Ronald Toh Kuan Hai,
Perlyn Zekui Kwek,
Mei Yee Wong,
Deepika Raman,
Qi An Ang,
Vithya Manoharan,
Susmitha Vuddagiri,
Monique Danielle Dawson,
Alison Tan,
Joma Kanikadu Joy,
Bong Hwa Gan,
Choon Bing Low,
Haoying Xu,
Siew Pheng Lim,
Hannes Hentze,
Joseph Cherian,
Chong Teik Tan,
Jackie Ang,
Kantharaj Ethirajulu,
Klement Foo,
Inderjeet Singh,
Weijun Xu
|
ChemMedChem
|
|
12 Feb 2026
|
Others
|
Experimental Drug Development Centre
|
Small-Molecule Drug Discovery Targeting RNAs: Hope or Hype? (Pending publish)
|
CongBao Kang,
Hung T. Nguyen,
David E. Heppner,
Bin Yu,
Weijun Xu
|
Journal of Medicinal Chemistry
|
|
12 Feb 2026
|
Others
|
Experimental Drug Development Centre
|
Macrocycles: On the Rise for Bridging Small Molecules and Biologics (Pending publish)
|
Klement Foo,
Kantharaj Ethirajulu,
Weijun Xu
|
Journal of Medicinal Chemistry
|
|
11 Dec 2025
|
Others
|
Experimental Drug Development Centre
|
Structural and Computational Biology: Compete or Complement? (Pending publish)
|
CongBao Kang,
Haiwei Song,
Weijun Xu
|
Journal of Medicinal Chemistry
|
|
7 Aug 2025
|
Others
|
Experimental Drug Development Centre
|
Discovery of an Orally Bioavailable Reversible Covalent SARS-CoV-2 Mpro Inhibitor with Pan-Coronavirus Activity
|
Qian Wen Tan,
Subramanyam Vankadara,
Jia Yi Fong,
Yi Yang See,
Nithya Baburajendran,
Pearly Shuyi Ng,
Weijun Xu,
Yee Khoon Yeo,
Weiling Wang,
Choon Heng Low,
Li Hong Tan,
Eileen Gui Ju Tay,
Yun Xuan Wong,
Chuhui Huang,
Sandra Sim,
Shi Hua Ang,
Hannah Hui Min Toh,
Juliana Mohammad,
Gang Wang,
Boping Liu,
Shu Ting Tan,
Perlyn Zekui Kwek,
Monique Danielle Dawson,
Qin Yao Oh,
Xiaoying Koh,
Joma Joy,
May Ann Lee,
Walter Stunkel,
Vishal Pendharkar,
Hannes Hentze,
Siew Pheng Lim,
Kantharaj Ethirajulu,
C. S. Brian Chia,
Joseph Cherian
|
Journal of Medicinal Chemistry
|
|
12 May 2025
|
Others
|
Experimental Drug Development Centre
|
An Evolving Landscape of Small Molecules Targeting SARS-CoV-2: What Are We Awaiting Beyond 3CLpro Inhibitors? (Pending publish)
|
CongBao Kang,
Klement Foo,
Kantharaj Ethirajulu,
Weijun Xu
|
Journal of Medicinal Chemistry
|